Yasuto Koyama

Career

Representative, KOYAMA Pharma Consulting
Advisor, NPO-QA Center
In 1979, he joined Fujisawa Pharmaceutical Co., Ltd. and worked on formulation of sterile products at R&D Dept. and GMP quality assurance.
In 2003, he joined Eli Lilly Japan K.K. and served as a QA manager in R&D.
In 2007, he joined Shionogi & Co., Ltd. and served as the Quality Manager at Kanegasaki Plant then worked on manufacturing site administrative tasks related to GQP at QA Dept., the headquarters.
In 2019, he left Shionogi and then found KOYAMA Pharma Consulting .

Articles

2023/03/01 AD Quality System

The Initial Steps Toward Understanding GMP for Drugs: 3

1. Introduction In the previous article, I looked into ICH Q10 Pharmaceutical Quality System, a guideline covering the whole process of drugs from dev

2023/02/07 AD Quality System

The Initial Steps Toward Understanding GMP for Drugs: 2

1. Introduction In my previous article, I wrote about the importance of seeing GMP as a system which ensures quality of drug products i.e. quality sys

2023/01/26 AD Quality System

The Initial Steps Toward Understanding GMP for Drugs: 1

1. Introduction Taking this opportunity to write a serial, I would like to provide our readers who are involved in GMP-related tasks from rookies to t